规格: | 5mg | 产品价格: | 300 |
---|
规格: | 10mg | 产品价格: | 580 |
---|
规格: | 50mg | 产品价格: | 2400 |
---|
规格: | 100mg | 产品价格: | 4200 |
---|
Catalog Number GC14939
Molecular Formula C22H25NO2
Relative Molecular Mass 335.4
CAS Registry Number 101910-24-1
Formulation A solid
Purity ≥98%
Storage Room temperature
SMILES CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1
产品描述
Ki: 0.7 μM for cysteinyl-leukotriene receptor of guinea pig lung membranesREV 5901 is an antagonist of cysteinyl-leukotriene receptors.Cysteinyl leukotriene receptor 1, a receptor for cysteinyl leukotrienes, contributes to mediating various allergic and hypersensitivity reactions by binding the cysteinyl LTs (CysLTs; viz, LTC4, LTD4, and to a much lesser extent, LTE4) in humans and models of the reactions in other animals.In vitro: Previous in-vitro showed that REV 5901 had a Ki value of 0.7 μM vs. [3H]leukotriene D4 ([3H]-LTD4) binding to membranes from guinea pig lung. Against LTC4-, LTD4- and LTE4-induced contractions of guinea pig parenchymal strips, REV 5901 had Kb values of ca 3 μM and was relatively ineffective against contractions that was induced by other spasmogens. Moreover, in isolated guinea pig hearts, the peptiodoleukotriene-antagonist activity was also observed against the hemodynamic and vasoconstriction effects of LTD4. In addition, unlike other reported antagonists, REV 5901 was found to be ineffective against the multiple forms of cyclic nucleotide phosphodiesterases [1].In vivo: Animal study found that the oral antagonist activity had been shown with an LTD4-induced bronchoconstriction model and with an LTD4-induced wheal response model in guinea pigs [1].Clinical trial: So far, no clinical study has been conducted.Reference:[1] Van Inwegen, R.G.,Khandwala, A.,Gordon, R., et al. REV 5901: An orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profile. Journal of Pharmacology and Experimental Therapeutics 241, 117-124 (1987).
更多产品信息,请点击:https://www.glpbio.cn/search.php?catalog=GC14939原装进口,REV 5901,美国GlpBio品Pai大包装更优惠!
美国Glpbio是一家领先的小分子YZ剂、激活剂、化合物库、多肽和实验室试剂的供应商。公司经营范围广泛,产品涉及癌症、免疫学、神经科学、细胞凋亡、表观遗传学等20多个不同研究领域,拥有10000多种产品。总部位于美国加利福尼亚,营销网点遍及法国、德国、加拿大、日本、澳大利亚、新加坡、以色列等20多个国家地区,竭诚为各国的科研工作者提供优质的产品和专业的服务。
![](http://item.yiqi.com/pic/ConPic/4/3323125216116756959-14.jpg)
![](http://item.yiqi.com/pic/ConPic/4/3323126197516789367-14.jpg)
温馨提示:不可用于临床ZL。